Navigation Links
Summits on translational science bridge domains critical to health advancements

San Francisco, March 7, 2011 A ground-breaking pair of scientific meetings, the Joint Summits on Translational Science, open today with several hundred scientists, researchers, academic leaders, and nonprofit and corporate leaders in biomedicine who share a common interest in transforming biomedical research discoveries into clinical treatments and health promotion. AMIA, the association for informatics professionals, convenes the week-long Joint Summits on Translational Bioinformatics (TBI) and Clinical Research Informatics (CRI) to meet the knowledge-driven needs of translational scientists who use the Summits as a key venue in which to share the spectrum of their work in discovery-driven science from 'bench to bedside', find collaborative partners, and network with peers also interested in bridging innovation in biomedical research to patient care.

"AMIA's commitment to TBI and CRI is fundamental to its mission of bridging knowledge and collaboration across a continuum, from basic and applied research to public health and consumer areas," says Edward H. Shortliffe, MD, PhD, FACMI, president and CEO of AMIA. "The Joint Summits provide a unique opportunity for researchers in translational science to come together in a single venue, and to span the full range of informatics applications from basic human biology to clinical care."

"This meeting provides a unique opportunity to bring together the finest minds in TBI and CRI," says TBI Summit Chair Indra Neil Sarkar, PhD, MLIS, director of biomedical informatics and assistant professor at the University of Vermont's Center for Clinical and Translational Science. "The TBI Summit, now in its fourth year, has embraced the trans-disciplinary nature of translational bioinformatics to become the foremost forum for scientific pioneers in biology and health care."

TBI content at the Summit is broken down into four tracks: informatics concepts, tools and techniques to enable integrative translational bioinformatics research; informatics methods for the integrative analysis of molecular and clinical measurements; relating and representing phenotypes and disease for translational bioinformatics research; and informatics methods bridging basic science discoveries and clinical practice.

Keynote presentations feature Kenneth H. Buetow, PhD, director of the National Cancer Institute's Center for Bioinformatics and Information Technology; Carl Zimmer, lecturer at Yale University, journalist and author; and Lincoln Stein, MD, PhD, platform leader of Informatics and Bio-computing at Ontario Institute for Cancer Research. Collectively, these individuals exemplify contributions that translational scientists make in the health sector; analysis and presentation of scientific findings in the context of the role of genetics in complex human diseases such as cancer; and the application of sophisticated informatics technologies to solve major biomedical challenges.

CRI Summit Chair Philip R.O. Payne, PhD, chair of the Department of Biomedical Informatics at The Ohio State University explains, "The CRI Summit provides an unparalleled opportunity for individuals and organizations at all levels to develop and enhance a comprehensive understanding of the CRI landscape. Bringing TBI and CRI professionals together accelerates work at their intersecting areas of focus and introduces added value to both fields--an even greater benefit to the larger healthcare community."

CRI content at the Summit is broken down into multiple tracks: Research Planning and Participant Recruitment; Data Management, Sharing and Representation; People, Organizational, and Policy Issues; and Educational and Community Development. More information about the program sessions, the keynote speakers and attendees is online at

The AMIA Joint Summits will feature up-to-date coverage on Twitter @AMIAInformatix and #TBICRI11.


Contact: Nancy Light
American Medical Informatics Association

Related biology news :

1. 3 new informatics pilot projects to aid clinical and translational scientists nationwide
2. NIH Clinical and Translational Science Consortium grows to 39 members
3. Faculty of Translational Medicine boosts support for biomedical researchers
4. Prostate Cancer Translational Research in Europe meeting: Search for biomarkers continues
5. IRSF announces translational research award funding to test potential therapeutics for Rett syndrome
6. Science Translational Medicine adds 12 new associate scientific advisors
7. Covance Establishes New Discovery & Translational Services Group
8. Covance Establishes New Discovery & Translational Services Group
9. National Eye Institute hosts Translational Research and Vision Symposium
10. USC wins $56.8M NIH award for clinical and translational research
11. Strategies for translational research in the UK
Post Your Comments:
(Date:11/12/2015)... Nov. 12, 2015  Arxspan has entered into ... and Harvard for use of its ArxLab cloud-based ... tools. The partnership will support the institute,s efforts ... chemical research information internally and with external collaborators. ... for managing the Institute,s electronic laboratory notebook, compound ...
(Date:11/10/2015)... NEW YORK , Nov. 10, 2015 /PRNewswire/ ... refers to behavioral biometrics that helps to identify ... prevent fraud. Signature is considered as the secure ... for the identification of a particular individual because ... offers more accurate results especially when dynamic signature ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has been ... provide preclinical development services to the National Cancer Institute ... will provide scientific expertise, modern testing and support facilities, ... preclinical pharmacology and toxicology studies to evaluate potential cancer ... The PREVENT Cancer Drug Development Program is an ...
Breaking Biology News(10 mins):
(Date:12/1/2015)... 2015  CardioCell LLC, a Stemedica Cell Technologies ... cardiovascular indications, intends to proceed with finalizing a ... from a Heart Failure Advisory Board comprising cardiology ... Board members . In a recent meeting members ... and efficacy data from CardioCell,s on-going chronic heart ...
(Date:12/1/2015)... 1, 2015 Cepheid (Nasdaq: CPHD ) ... the Piper Jaffray Healthcare Conference in New ... is reaffirming its outlook for the fourth quarter of ... to discussing longer term business model expectations. ...  "We continue to be the fastest growing company of ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... physicians, aesthetic practitioners and aesthetics professionals from Central America and abroad for the ... in Panama City, Panama Feb. 17-19, 2016. Testart will present and discuss new ...
(Date:11/30/2015)... /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ), a leader in ... Business Act on Climate Pledge, alongside more than 140 companies ... Obama Administration to demonstrate an ongoing commitment to climate action ... COP21 Paris climate negotiations. ... Canada . --> BioAmber uses biotechnology to ...
Breaking Biology Technology: